Ken Op de Beeck

17PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Medical mycologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 02, 2026
Clinical evaluation of the CrossNN DNA methylation classifier for central nervous system tumors.

|Jun 24, 2026
In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.

|Dec 10, 2025
The technology landscape for detection of DNA methylation in cancer liquid biopsies.

Isabelle Neefs, Joe Ibrahim, Marc Peeters

|Nov 14, 2025
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies.

Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke

|Jan 17, 2025
Exploring the conformational space of ROS1 kinase domain and the impact of allosteric mutations.

Farhan Ul Haq, Juliana Fatima Vilachã, Ken Op de Beeck

|Dec 03, 2024
Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases.

Janah Vandenhoeck, Joe Ibrahim, Nele De Meulenaere

Pageof 3

Frequent Collaborators

5 joint publications

Guy Van Camp

4 joint publications

Joe Ibrahim

4 joint publications

Marc Peeters

3 joint publications

Timon Vandamme